Translate the text from English to Welsh.



 
The New Treatment Fund has enabled quicker access to over 265 medicines to treat more than 100 health conditions since it was established by the Welsh Government in 2017\.  

  

It has cut the average time it takes for newly\-recommended medicines to become available to patients by 85 per cent, from 90 to 13 days.  

  

The Fund has sped up access to medicines recommended by the National Institute for Health and Care Excellence (NICE) and the All Wales Medicines Strategy Group (AWMSG). The money announced today will ensure the Fund continues until April 2022\.  

  

Treatment for health conditions including Cancer, HIV, Multiple Sclerosis  and Cystic Fibrosis have all been made available much quicker to patients thanks to the £80m fund. As well as the cost of medicines, the New Treatment Fund covers the costs of equipment needed to administer a medicine and the cost of holding extra clinics to treat and monitor patients.  

  

Medicines including Sarilumab and Tocilizumab, made available via the New Treatment Fund to treat arthritis and rheumatoid arthritis, are also now able to be rapidly deployed by the NHS for use in the management of COVID\-19\.  

  

Minister for Health and Social Services, Vaughan Gething, said:



> “Since we established the New Treatment Fund it has helped to prolong and improve the lives of thousands of people across Wales .Patients and their families are benefiting from improved access to life saving and life changing medicines. I’m pleased to confirm the extension of the Fund which reaffirms our commitment to ensure that people receive the latest recommended treatments quickly, no matter where they live in Wales.”







Translation:


 
Ers iddi gael ei sefydlu gan Lywodraeth Cymru yn 2017, mae’r Gronfa Triniaethau Newydd wedi cyflymu mynediad at dros 265 o feddyginiaethau i drin mwy na 100 o gyflyrau iechyd.  

  

Mae wedi lleihau’r amser y mae’n ei gymryd ar gyfartaledd i feddyginiaethau, sydd newydd eu hargymell, ddod ar gael i gleifion, gan ei leihau 85%, o  90 i 13 o ddiwrnodau.  

  

Mae’r Gronfa wedi cyflymu’r broses o gael mynediad at feddyginiaethau a argymhellir gan y Sefydliad Cenedlaethol dros Ragoriaeth mewn Iechyd a Gofal (NICE) a Grŵp Strategaeth Feddyginiaethau Cymru (AWMSG). Bydd yr arian a gyhoeddir heddiw yn sicrhau bod y Gronfa’n parhau tan fis Ebrill 2022\.  

  

Mae triniaethau ar gyfer cyflyrau iechyd, gan gynnwys canser, HIV, sglerosis ymledol a ffeibrosis systig, i gyd wedi dod ar gael i gleifion yn llawer cynt, diolch i’r gronfa o £80m. Yn ogystal â chost y meddyginiaethau, mae’r Gronfa Triniaethau Newydd yn talu am gostau’r cyfarpar y mae ei angen i weini’r feddyginiaeth, a’r gost o gynnal clinigau ychwanegol i drin a monitro’r claf.  

  

Mae meddyginiaethau, gan gynnwys Sarilumab a Tocilizumab, sydd wedi dod ar gael drwy’r Gronfa Triniaethau Newydd i drin arthritis ac arthritis gwynegol, bellach hefyd ar gael yn ddi\-oed i’r GIG eu defnyddio i helpu i reoli COVID\-19\.  

  

Dywedodd y Gweinidog Iechyd a Gwasanaethau Cymdeithasol, Vaughan Gething:



> “Ers inni sefydlu’r Gronfa Triniaethau Newydd, mae wedi helpu i ymestyn a gwella bywydau miloedd o bobl ledled Cymru. Mae cleifion a’u teuluoedd yn elwa ar y ffaith bod mynediad gwell at feddyginiaethau sy’n gallu newid ac achub bywydau. Mae’n bleser gennyf gadarnhau y bydd y Gronfa’n cael ei hymestyn, gan adlewyrchu ein hymrwymiad i sicrhau bod pobl yn gallu cael gafael yn gyflym ar y triniaethau diweddaraf sydd wedi eu hargymell, waeth ble yng Nghymru maen nhw’n byw.”